All In MedTech

FDA Clearance Tracker · P010047-S026

PROGEL PLEURAL AIR LEAK SEALANT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 25, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 25, 2013

Approved

Time to decision

247 days

Received Nov 20, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010047-S026
Device name
PROGEL PLEURAL AIR LEAK SEALANT
Applicant
Neomend, Inc.
Applicant location
Irvine, CA
Received
Nov 20, 2012
Decided
Jul 25, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P010047

Device type

Device class
Class III

Every decision under product code NBE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A CHANGE IN THE SHIPPING TEMPERATURE RANGE TO 1ºC TO 30°C TO ALLOW FOR BRIEF POSSIBLE EXTREMES IN TEMPERATURE DURING SHIPMENT. THE AGENCY NOTES THAT THE "KEEP REFRIGERATED" LABEL, C-00473, WILL BE AFFIXED TO THE SHIPPING CONTAINER.

Source documents

Other decisions for Neomend, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.